Results 181 to 190 of about 2,655 (208)

Erenumab/galcanezumab

Reactions Weekly
  +4 more sources

Galcanezumab bei episodischem und chronischem Clusterkopfschmerz

Der Schmerz, 2022
Pohl, Heiko, Holle-Lee, Dagny, Broicher, Sarah D, Schwerdtner, Inka, Gantenbein, Andreas R, Gaul, Charly   +5 more
openaire   +1 more source

Galcanezumab bei therapierefraktärer Migräne

DNP - Der Neurologe & Psychiater, 2021
openaire   +1 more source

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

New England Journal of Medicine, 2019
Peter Goadsby, Massimo Leone, Andrew H Ahn   +2 more
exaly  

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Lancet Neurology, The, 2020
Michel Lantéri-Minet, Patricia Pozo-Rosich, Holland C Detke   +2 more
exaly  

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

Cephalalgia, 2018
Manjit S Matharu
exaly  

Evaluation of Galcanezumab for the Prevention of Episodic Migraine

JAMA Neurology, 2018
Virginia L Stauffer, Qi Zhang, Jessica Ailani   +2 more
exaly  

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention

JAMA Neurology, 2018
Peter Goadsby, Qi Zhang, David W Dodick
exaly  

Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials

European Journal of Neurology, 2020
Sriram Govindan, Sheena Aurora
exaly  

Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study

Cephalalgia, 2018
Holland C Detke
exaly